LANCRIX

Gemcitabine hydrochloride, ≥99%

Catalog No. 177147

Identification
Synonyms2′-Deoxy-2′,2′-difluorocytidine; dFdC, Gemzar (Lilly), LY-188011, dFdC, dFdCyd
CAS No.122111-03-9
M.F.

C9H11F2N3O4 · HCl

M.W.299.66
MDL No.MFCD01735988
Technical Data
AppearanceWhite crystalline powder
Specific Rotation (°)+43°~+50°
Assay≥99% HPLC
SolubilitySoluble in Water, Acetone and DMSO
StorageRoom temperature
ApplicationGemcitabine hydrochloride is an antineoplastic.
Safety Data
SymbolGHS08
Hazard StatementsH360
Precautionary StatementsP201-P308 + P313
Hazard SymbolsXn
Risk StatementsR63-62
Safety StatementsS53-36/37
WGK Germany3
Reference

Hertel et al (1990) Evaluation of the antitumor activity of Gemcitabine (2',2'-Difluoro-2'-deoxycytidine). Cancer Res. 50 4417. PMID: 2364394.

Heinemann et al (1995) Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism. Semin.Oncol. 22 (Suppl. 11) 11. PMID: 7481839.

Plunkett et al (1995) Preclinical characteristics of gemcitabine. Anticancer Drugs 6 (Suppl. 6) 7. PMID: 8718419.

Availability: Ships in 1-3 days

For research use only.

Inquire

(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject 177147, Gemcitabine hydrochloride, ≥99%, 122111-03-9
*Message
*Code If it’s not clear, please click on the picture to change one.